Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.80
+0.25 (2.37%)
May 8, 2026, 1:46 PM CST

TPEX:4186 Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
28.0522.88-10.683.17-118.53
Depreciation & Amortization
19.6920.6225.928.1830.39
Loss (Gain) From Sale of Assets
-0.03-0.38-0.010.03
Asset Writedown & Restructuring Costs
--9.151.896.05
Loss (Gain) From Sale of Investments
-2.4314.691.23-2.58-2.06
Provision & Write-off of Bad Debts
8.413.581.840.790.1
Other Operating Activities
-2.33-1.15-0.990.235.78
Change in Accounts Receivable
-6.65-50.1310.014.99-13.6
Change in Inventory
-1.423.062.480.21-0.41
Change in Accounts Payable
5.05-1.260.3-0.81-2.32
Change in Unearned Revenue
2.389.550.72-35.4837.69
Change in Other Net Operating Assets
2.38-13.54-26.96-21.188.8
Operating Cash Flow
53.138.3312.61-20.59-48.08
Operating Cash Flow Growth
538.04%-33.95%---
Capital Expenditures
-33.36-3.96-11.94-7.28-15.19
Sale of Property, Plant & Equipment
-0.261.41.16-
Sale (Purchase) of Real Estate
-3.66----
Investment in Securities
-9.660.29-1.8-3.01-
Other Investing Activities
-1.581.19-1.360.3-0
Investing Cash Flow
-48.25-2.22-13.7-8.83-15.2
Short-Term Debt Issued
40-49.0623.09-
Long-Term Debt Issued
--164030.7
Total Debt Issued
40-65.0663.0930.7
Short-Term Debt Repaid
--40---9.05
Long-Term Debt Repaid
-10.47-41.92-40.38-34.69-35.62
Total Debt Repaid
-10.47-81.92-40.38-34.69-44.67
Net Debt Issued (Repaid)
29.53-81.9224.6728.39-13.97
Other Financing Activities
----0.110.05
Financing Cash Flow
29.53-81.9224.6728.28-13.92
Net Cash Flow
34.41-75.8123.58-1.14-77.2
Free Cash Flow
19.774.370.67-27.87-63.28
Free Cash Flow Growth
352.74%554.72%---
Free Cash Flow Margin
5.42%1.23%0.21%-8.76%-26.00%
Free Cash Flow Per Share
0.220.050.01-0.31-0.70
Cash Interest Paid
-7.417.276.137.43
Cash Income Tax Paid
---0.01-0
Levered Free Cash Flow
0.3-33.6560.04-11.92-15.82
Unlevered Free Cash Flow
4.37-29.0164.6-8.09-11.17
Change in Working Capital
1.74-52.32-13.45-52.2730.15
Source: S&P Global Market Intelligence. Standard template. Financial Sources.